d(GC) - Association of Biotechnology and Pharmacy
d(GC) - Association of Biotechnology and Pharmacy
d(GC) - Association of Biotechnology and Pharmacy
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Current Trends in <strong>Biotechnology</strong> <strong>and</strong> <strong>Pharmacy</strong><br />
Vol. 6 (2) 119-144 April 2012, ISSN 0973-8916 (Print), 2230-7303 (Online)<br />
32. Contraloría de Panama. XI Censo de<br />
Población y VII de Vivienda, 2010:<br />
Resultados Finales (Volumen V: Migración<br />
y Fecundidad). Cuadro 7. . http://<br />
www.contraloria.gob.pa/inec/<br />
cuadros.aspx?ID=000106 Accessed 31,<br />
Jan 2012<br />
33. Kobayashi, S., Boggon, T.J., Dayaram, T.,<br />
Janne, P.A., Kocher, O., Meyerson, M.,<br />
Johnson, B.E., Eck, M.J., Tenen, D.G., <strong>and</strong><br />
Halmos, B. (2005). EGFR mutation <strong>and</strong><br />
resistance <strong>of</strong> non-small-cell lung cancer to<br />
gefitinib. N Engl J Med, 352: 786-92.<br />
34. Bos, J. (1989). ras Oncogenes in Human<br />
Cancer: A Review. Cancer Research, 49:<br />
4682-4689.<br />
35. Pao, W., Wang, T.Y., Riely, G.J., Miller, V.A.,<br />
Pan, Q., Ladanyi, M., Zakowski, M.F.,<br />
Heelan, R.T., Kris, M.G., <strong>and</strong> Varmus, H.E.<br />
(2005). KRAS mutations <strong>and</strong> primary<br />
resistance <strong>of</strong> lung adenocarcinomas to<br />
gefitinib or erlotinib. PLoS Med, 2: e17.<br />
36. Borras, E., Jurado, I., Hernan, I., Gamundi,<br />
M.J., Dias, M., Marti, I., Mane, B., Arcusa,<br />
A., Agundez, J.A., Blanca, M., <strong>and</strong> Carballo,<br />
M. (2011). Clinical pharmacogenomic<br />
testing <strong>of</strong> KRAS, BRAF <strong>and</strong> EGFR<br />
mutations by high resolution melting<br />
analysis <strong>and</strong> ultra-deep pyrosequencing.<br />
BMC Cancer, 11: 406.<br />
37. Chen, H.Y., Yu, S.L., Chen, C.H., Chang,<br />
G.C., Chen, C.Y., Yuan, A., Cheng, C.L.,<br />
Wang, C.H., Terng, H.J., Kao, S.F., Chan,<br />
W.K., Li, H.N., Liu, C.C., Singh, S., Chen,<br />
W.J., Chen, J.J., <strong>and</strong> Yang, P.C. (2007). A<br />
five-gene signature <strong>and</strong> clinical outcome in<br />
non-small-cell lung cancer. N Engl J Med,<br />
356: 11-20.<br />
38. Hamilton, S. <strong>and</strong> Aaltonen, L. (2000). World<br />
Health Organization Classification <strong>of</strong><br />
Tumours. Pathology <strong>and</strong> Genetics <strong>of</strong><br />
Tumours <strong>of</strong> the Digestive Tract. , IARC<br />
Press, Lyon, France, pp. 102-143.<br />
Rebecca E. Smith <strong>and</strong> Juan Miguel Pascale<br />
138<br />
39. Kwak, E.L. <strong>and</strong> Chung, D.C. (2007).<br />
Hereditary colorectal cancer syndromes: an<br />
overview. Clin Colorectal Cancer, 6: 340-4.<br />
40. National Comprehensive Cancer Network.<br />
Clinical Practice Guidelines in Oncology:<br />
Colorectal Cancer Screening.; http://<br />
www.nccn.org/pr<strong>of</strong>essionals/physician_gls/<br />
f_guidelines.asp#site Accessed 31, Aug<br />
2011<br />
41. Jasperson, K.W., Tuohy, T.M., Neklason,<br />
D.W., <strong>and</strong> Burt, R.W. (2010). Hereditary<br />
<strong>and</strong> familial colon cancer. Gastroenterology,<br />
138: 2044-58.<br />
42. Kohlmann, W. <strong>and</strong> Gruber, S.B. Lynch<br />
Syndrome. http://www.ncbi.nlm.nih.gov/<br />
books/NBK1211/ Accessed 31, Jan 2012<br />
43. Alonso-Espinaco, V., Giraldez, M.D.,<br />
Trujillo, C., van der Klift, H., Munoz, J.,<br />
Balaguer, F., Ocana, T., Madrigal, I., Jones,<br />
A.M., Echeverry, M.M., Velez, A.,<br />
Tomlinson, I., Mila, M., Wijnen, J., Carvajal-<br />
Carmona, L., Castells, A., <strong>and</strong> Castellvi-Bel,<br />
S. (2011). Novel MLH1 duplication identified<br />
in Colombian families with Lynch syndrome.<br />
Genet Med, 13: 155-60.<br />
44. Giraldo, A., Gomez, A., Salguero, G.,<br />
Garcia, H., Aristizabal, F., Gutierrez, O.,<br />
Angel, L.A., Padron, J., Martinez, C.,<br />
Martinez, H., Malaver, O., Florez, L., <strong>and</strong><br />
Barvo, R. (2005). MLH1 <strong>and</strong> MSH2<br />
mutations in Colombian families with<br />
hereditary nonpolyposis colorectal cancer<br />
(Lynch syndrome)—description <strong>of</strong> four<br />
novel mutations. Fam Cancer, 4: 285-90.<br />
45. Gomez, A., Salguero, G., Garcia, H.,<br />
Aristizabal, F., Gutierrez, O., Angel, L.A.,<br />
Padron, J., Martinez, C., Martinez, H.,<br />
Malaver, O., Barvo, R., <strong>and</strong> Giraldo, A.<br />
(2005). Detection mutations in the DNA<br />
mismatch repair genes <strong>of</strong> hMLH1 <strong>and</strong><br />
hMSH2 genes in Colombian families with<br />
suspicion <strong>of</strong> hereditary non-polyposis<br />
colorectal carcinoma (Lynch syndrome).<br />
Biomedica, 25: 315-24.